1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Early Stage: new trials by email Literature Review of Early Stage trials Research Report on Early Stage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma Sintilimab - Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage | Phase 2 | Completed | Sun Yat-sen University | 55 | 2019-04-28 | 2022-06-09 |
anlotinib (1) · sintilimab (1)
China (1)
Zhiming Li (1)